Dr Aleksandra Singh
About Dr Aleksandra Singh
Dr. Aleksandra Singh is an esteemed Oligonucleotide Synthesis Lead, known for her significant contributions to cancer research and recognized on Forbes' 30 under 30 Science and Healthcare list in 2018.
Title and Role: Oligonucleotide Synthesis Lead
Dr. Aleksandra Singh holds the position of Oligonucleotide Synthesis Lead. This role involves overseeing the synthesis of oligonucleotides, which are short DNA or RNA molecules crucial for various biological and medical research applications. Dr. Singh's expertise in this area supports advancements in genetic research and therapeutic development.
Education and Expertise in Cancer Research
Dr. Aleksandra Singh earned a PhD in Cancer Research from the Francis Crick Institute in London. Her academic journey also includes an MRes in Translational Cancer Medicine from King's College London. These credentials illustrate her deep understanding of cancer biology and her ability to translate research findings into potential treatments.
Principal Investigator in International Collaborative Projects
Dr. Aleksandra Singh has served as the principal investigator in over 15 large international collaborative projects. Her leadership in these projects reflects her capacity to coordinate and contribute to significant global research efforts, ensuring the integration of diverse scientific perspectives and resources.
Published Research Contributions
Dr. Aleksandra Singh's scientific contributions have been published in prominent journals such as Current Biology, Cell, and Nature Medicine. These publications demonstrate the recognition of her research within the scientific community and her continued impact on the fields of biology and medicine.
Patent Applications and Innovations
Dr. Aleksandra Singh's work has led to multiple patent applications, highlighting her role in developing novel techniques and applications in oligonucleotide synthesis and cancer research. These patents underscore her contributions to advancing scientific methods and potentially offering new solutions in medical research.
Recognition by Forbes 30 Under 30
In 2018, Dr. Aleksandra Singh was recognized by Forbes on their 30 under 30 Science and Healthcare list. This accolade acknowledges her significant contributions to these fields at a relatively young age and underscores her influence and potential within the scientific community.